Journals / Tüberküloz ve Toraks / 2015 / Cilt: 63 - Sayı: 4

Homozygous methylene tetra hydro folate reductase-677TT gene mutation: Case of pulmonary thromboembolism

Pages
298–299
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

DORUK, S., İNCE, Ö., KARADENİZ, G., KIR, S. B., GÜNDÜZ, D. (2022). Homozygous methylene tetra hydro folate reductase-677TT gene mutation: Case of pulmonary thromboembolism. Tüberküloz ve Toraks, Cilt: 63 - Sayı: 4, 298–299. https://ajindex.com/articles/618571

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998;279:458-62.
  2. Heit JA, Mohr DN, Silverstein MD, Petterson MD, O'Fallon WM, Melton LJ. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000;160:761-8. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol 2007;44:62-9.
  3. Piazza G, Goldhaber SZ. Acute pulmonary embolism: Epidemiology and diagnosis. Circulation 2006;114:28-32. Jakubowski H. Pathophysiological consequences of homocysteine excess. J Nutr 2006;136:1741-9.
  4. Hotoleanu C, Trifa A, Popp R, Fodor D. The Importance of Homozygous Polymorphisms of Methylenetetrahydrofolate Reductase Gene in Romanian Patients with Idiopathic Venous Thromboembolism. Balkan Med J 2013;30:197-203.
  5. Moheimani F, Jackson DE. Venous thromboembolism: classification, risk factors, diagnosis, and management. ISRN Hematol 2011;2011:124610.